Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Significance of Biological Markers in Patients With ALI/ARDS

NCT00217880 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT00217880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Significance of Biological Markers in Patients With ALI/ARDS
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2004
Completion date
June 30, 2009
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult